Aquarius Surgical Technologies (Aquarius Surgical Technologies) EV-to-EBIT : -11.91 (As of May. 13, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Aquarius Surgical Technologies EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Aquarius Surgical Technologies's Enterprise Value is $3.55 Mil. Aquarius Surgical Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.30 Mil. Therefore, Aquarius Surgical Technologies's EV-to-EBIT for today is -11.91.

The historical rank and industry rank for Aquarius Surgical Technologies's EV-to-EBIT or its related term are showing as below:

AQQRF' s EV-to-EBIT Range Over the Past 10 Years
Min: -12.53 Med: -3.79 Max: 7.63
Current: -12.18

During the past 13 years, the highest EV-to-EBIT of Aquarius Surgical Technologies was 7.63. The lowest was -12.53. And the median was -3.79.

AQQRF's EV-to-EBIT is ranked worse than
100% of 456 companies
in the Medical Devices & Instruments industry
Industry Median: 20.475 vs AQQRF: -12.18

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Aquarius Surgical Technologies's Enterprise Value for the quarter that ended in Dec. 2023 was $2.92 Mil. Aquarius Surgical Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.30 Mil. Aquarius Surgical Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -10.19%.

Aquarius Surgical Technologies EV-to-EBIT Historical Data

The historical data trend for Aquarius Surgical Technologies's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aquarius Surgical Technologies EV-to-EBIT Chart

Aquarius Surgical Technologies Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-EBIT

Get a 7-Day Free Trial

-4.41

-7.55

-5.18

-7.16

-6.99

Aquarius Surgical Technologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															-5.65	-6.99	-7.91	-7.97	-10.11

Competitive Comparison of Aquarius Surgical Technologies's EV-to-EBIT

For the Medical Devices subindustry, Aquarius Surgical Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aquarius Surgical Technologies's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aquarius Surgical Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Aquarius Surgical Technologies's EV-to-EBIT falls into.

Aquarius Surgical Technologies EV-to-EBIT Calculation

Aquarius Surgical Technologies's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	3.550	/	-0.298
	=	-11.91

Aquarius Surgical Technologies's current Enterprise Value is $3.55 Mil.
Aquarius Surgical Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.30 Mil.

Aquarius Surgical Technologies (OTCPK:AQQRF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Aquarius Surgical Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-0.298	/	2.92491664
	=	-10.19 %

Aquarius Surgical Technologies's Enterprise Value for the quarter that ended in Dec. 2023 was $2.92 Mil.
Aquarius Surgical Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.30 Mil.

Aquarius Surgical Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Aquarius Surgical Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Aquarius Surgical Technologies (Aquarius Surgical Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aquarius Surgical Technologies Inc (OTCPK:AQQRF) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

ASTI:Canada

Address

89 Scollard Street, Toronto, ON, CAN, M5R 1G4

Website

https://aquariussurgical.com

Aquarius Surgical Technologies Inc is engaged in the development, sale, distribution, marketing, and exploitation of laser-driven technologies for use in surgical environments, principally in the field of urology. The company derives revenue from the sale of medical devices and fiber-optic delivery devices. Geographically, it has a presence in Canada, the United States, and the Dominican Republic.